Research

Energy balance

Macrophage-specific lipoprotein lipase (LPL) promotes atherosclerosis by acting as a bridging molecule for remnant lipoprotein uptake, leading to foam cell formation and plaque progression.

LPL helps clear fat from blood, but in immune cells within artery walls, it helps build plaques. Therapies targeting LPL must distinguish between clearing blood fat (good) and feeding artery plaques (bad).

ModerateSupportsMEDIUM confidence
When this process occurs in macrophages, LPL acted as a bridging molecule for remnant uptake to increase foam cell formation and lesion progression (Figure 1) [107].
Rui Shang et al. · Journal of Pharmacy & Pharmaceutical Sciences · 2024

Why this rating

Supported by animal models (Apoe-/- mice, rabbit macrophages) and in vitro studies.

Source

Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease

Rui Shang et al. · Journal of Pharmacy & Pharmaceutical Sciences · 2024

DOI 10.3389/jpps.2024.13199

narrative_reviewCited 18×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →